Review Article
Serum and Urine Biomarkers for Human Renal Cell Carcinoma
Table 2
Potential urinary biomarkers in RCC.
| | Marker | Author (yr) | RCC versus CG |
| | NMP-22 | Kaya et al. (2005) [76] | ↑ | | Ozer et al. (2002) [77] | ↑ | | Huang et al. (2000) [78] | ↑ | | NGAL | Di Carlo (2013) [82] | ↑ | | Morrissey et al. (2011) [83] | ↑ | | KIM-1 | Morrissey et al. (2011) [83] | ↑ | | MMPs |
di Carlo (2012) [84] | ↑ | | AQP-1 |
Morrissey and Kharasch (2013) [86] | ↑ | | AQP-1 | Morrissey et al. (2014) [87] | ↑ | | PLIN2 | Morrissey and Kharasch (2013) [86] | ↑ | | PLIN2 |
Morrissey et al. (2014) [87] | ↑ |
|
|
RCC: renal cell carcinoma; CG: control group; NMP-22: nuclear matrix protein-22; KIM-1: kidney injury molecule-1; MMP: matrix metalloproteinases; AQP-1: aquaporin-1; PLIN2: Perilipin 2.
|
